Department Of Hepatology 1
1. Сase report of syphilitic hepatitis
2. Acute-on-chronic liver failure (ACLF): the ‘Kyoto Consensus’—steps from Asia
3. Joint position statement from the Middle East and North Africa and sub-Saharan Africa on continuing to endorse the MAFLD definition
4. Joint position statement from the Middle East and North Africa and sub-Saharan Africa on continuing to endorse the MAFLD definition
5. Joint position statement from the Middle East and North Africa and sub-Saharan Africa on continuing to endorse the MAFLD definition
6. Joint position statement from the Middle East and North Africa and sub-Saharan Africa on continuing to endorse the MAFLD definition
7. First report from a single center retrospective study in Kazakhstan on acute myeloid leukemia treatment outcomes
8. A global action agenda for turning the tide on fatty liver disease
9. A global action agenda for turning the tide on fatty liver disease
10. A global action agenda for turning the tide on fatty liver disease
11. A global action agenda for turning the tide on fatty liver disease
12. A global action agenda for turning the tide on fatty liver disease
13. Advancing the global public health agenda for NAFLD: a consensus statement
14. Advancing the global public health agenda for NAFLD: a consensus statement
15. Massive Retroperitoneal and Subcutaneous Emphysema after Transanal Excision of Rectal Cancer
16. Global, regional, and national burden of chronic kidney disease in adults, 1990–2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023
17. Kidney Transplantation in Kazakhstan: 10-Year Single Center Experience
18. Kidney transplantation outcomes: Single center experience
19. Liver transplantation: A 10-year low-volume transplant center experience in kazakhstan
20. Characteristics of Hepatitis B and C Infections in Hemodialysis Patients in Almaty, Kazakhstans Largest City
21. Global burden of metabolic diseases, 1990–2021
22. Global burden of metabolic diseases, 1990–2021
23. Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021
24. Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021
25. Erratum: Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021 (eClinicalMedicine (2024) 76, (S2589537024004279), (10.1016/j.eclinm.2024.102848))
26. Erratum: Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021 (eClinicalMedicine (2024) 76, (S2589537024004279), (10.1016/j.eclinm.2024.102848))
27. Global burden of disease attributable to metabolic risk factors in adolescents and young adults aged 15–39, 1990–2021
28. Global burden of disease attributable to metabolic risk factors in adolescents and young adults aged 15–39, 1990–2021
1